Disparities in Nirsevimab Uptake Across a Pediatric Primary Care Network
{{output}}
Objective: Nirsevimab, a monoclonal antibody for respiratory syncytial virus (RSV) prophylaxis, debuted during the 2023-2024 RSV season. The objective of this study was to examine the distribution of nirsevimab to determine facto... ...
